StockData
GSK plc logo

GSK plc (GSK) stock

GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 9/30
$49.24−1.17 (-2.32%)

Close on Nov 17, 2026Market cap $106.25BP/E 13.4Yield –

GSK EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

GSK's EV/EBITDA was 9.0× on Nov 11, 2026, against 13.3× a year earlier. Over the last 5 years it ranged from 7.7× to 17.9×, with a median of 9.6×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20269.0×−4.4
2025Dec 31, 202513.4×+5.6
2024Dec 31, 20247.7×−1.1
2023Dec 29, 20238.9×−4.3
2022Dec 30, 202213.1×−0.3
2021Dec 31, 202113.4×+2.8
2020Dec 31, 202010.7×−4.1
2019Dec 31, 201914.8×−0.1
2018Dec 31, 201814.9×−3.6
2017Dec 29, 201718.5×+12.7
2016Dec 30, 20165.8×–

More GSK figures

See a number that looks wrong?